Literature DB >> 32958687

Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.

Alexandre E Nowill1, Pedro O de Campos-Lima2,3.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), which rapidly became a pandemic of global proportions. Sepsis is commonly present with high lethality in the severe forms of the disease. The virus-induced cytokine storm puts the immune system in overdrive at the expense of the pathogen-specific immune response and is likely to underlie the most advanced COVID-19 clinical features, including sepsis-related multiple organ dysfunction as well as the pathophysiological changes found in the lungs. We review the major therapeutic strategies that have been considered for sepsis and might be amenable to repurposing for COVID-19. We also discuss two different immunization strategies that have the potential to confer antiviral heterologous protection: innate-induced trained immunity and adaptive-induced immune response resetting.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32958687     DOI: 10.4049/jimmunol.2000892

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

Review 1.  Immune-Mediated Mechanisms of COVID-19 Neuropathology.

Authors:  Cordelia Dunai; Ceryce Collie; Benedict D Michael
Journal:  Front Neurol       Date:  2022-05-19       Impact factor: 4.086

2.  Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.

Authors:  Tingxuan Gu; Simin Zhao; Guoguo Jin; Mengqiu Song; Yafei Zhi; Ran Zhao; Fayang Ma; Yaqiu Zheng; Keke Wang; Hui Liu; Mingxia Xin; Wei Han; Xiang Li; Christopher D Dong; Kangdong Liu; Zigang Dong
Journal:  Front Immunol       Date:  2021-01-28       Impact factor: 7.561

3.  Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patients.

Authors:  Prashant R Tembhare; Harshini Sriram; Gaurav Chatterjee; Twinkle Khanka; Anant Gokarn; Sumeet Mirgh; Akhil Rajendra; Anumeha Chaturvedi; Sitaram G Ghogale; Nilesh Deshpande; Karishma Girase; Kajal Dalvi; Sweta Rajpal; Nikhil Patkar; Bhakti Trivedi; Amit Joshi; Vedang Murthy; Nitin Shetty; Sudhir Nair; Ashwini More; Sujeet Kamtalwar; Preeti Chavan; Vivek Bhat; Prashant Bhat; Papagudi G Subramanian; Sudeep Gupta; Navin Khattry
Journal:  Immunol Cell Biol       Date:  2021-10-27       Impact factor: 5.853

Review 4.  Prophylactic and therapeutic insights into trained immunity: A renewed concept of innate immune memory.

Authors:  Suresh Bindu; Satyabrata Dandapat; Rajendran Manikandan; Murali Dinesh; Anbazhagan Subbaiyan; Pashupathi Mani; Manish Dhawan; Ruchi Tiwari; Muhammad Bilal; Talha Bin Emran; Saikat Mitra; Ali A Rabaan; Abbas Al Mutair; Zainab Al Alawi; Saad Alhumaid; Kuldeep Dhama
Journal:  Hum Vaccin Immunother       Date:  2022-03-03       Impact factor: 4.526

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.